GSK Plc (GLAXF)
30.15
+0.60
(+2.03%)
USD |
OTCM |
Feb 11, 11:35
GSK Shareholders Equity (Quarterly) : 22.03B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Silence Therapeutics Plc | 74.06M |
| Adaptimmune Therapeutics Plc | -70.96M |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | 34.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.21B |
| Total Liabilities (Quarterly) | 60.66B |
| Debt to Equity Ratio | 1.082 |
| Current Ratio | 0.8186 |
| Net Debt Paydown Yield | -0.46% |